Business Context and Reporting Period
This Form 8-K filing by Q/C Technologies, Inc. (formerly TNF Pharmaceuticals, Inc.) covers the reporting period of September 22, 2025. The company, incorporated in Delaware, is reporting a corporate name change and a corresponding change in its stock ticker symbol on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and administrative changes rather than financial performance.
Material Changes
- Corporate Name Change: Effective September 22, 2025, the company changed its name from "TNF Pharmaceuticals, Inc." to "Q/C Technologies, Inc."
- Stock Ticker Symbol Change: Effective September 25, 2025, prior to market open, the common stock ceased trading under the symbol "TNFA" and began trading under the symbol "QCLS".
- Security Rights: The name change does not affect the rights of security holders, and there is no change to the company's CUSIP number.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on future outlook, or specific risk factors related to operations. The document notes that stockholder approval was not required for the name change pursuant to Section 242 of the Delaware General Corporation Law. Press releases regarding the name and symbol changes are included as exhibits but are not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the new ticker symbol "QCLS" on the Nasdaq Capital Market.
- Confirm that existing holdings under the former symbol "TNFA" have been automatically updated to "QCLS" by the broker.
- Review the Certificate of Amendment (Exhibit 3.1) for any other potential bylaw changes not explicitly detailed in the summary.
- Check subsequent filings for the company's first financial report under the new name to assess operational continuity.